Craif Raises $22M to Expand AI-Powered Early Cancer Detection
Craif secures $22M to revolutionize early cancer detection with AI and microRNA technology. Learn about their U.S. expansion and future plans.
Matilda
Craif Raises $22M to Expand AI-Powered Early Cancer Detection Craif Raises $22M to Expand AI-Powered Early Cancer Detection Early cancer detection remains one of the most powerful tools in reducing cancer-related deaths, but traditional methods often fall short in accessibility and comfort. If you're searching for early cancer detection startup news , or wondering about AI-driven cancer detection advancements , Craif is leading a promising charge. Recently, this innovative company secured $22 million in Series C funding to further its mission of revolutionizing cancer screening with AI-powered microRNA (miRNA) analysis . Craif’s approach, using a non-invasive urine-based test, aims to make early-stage cancer detection more accurate, affordable, and accessible. Image Credits:Craif / Craif Cancer continues to be a global health crisis, accounting for nearly 20 million new cases and 9.7 million deaths in 2022 , according to the National Cancer Institute. That number is projected to soar to 29.9 million by 2040, highlighting the …